Fennec Pharmaceuticals Inc. (FENC)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$10.61−$0.0150 (−0.14%) on the dayAs of the close; data may be delayed.
FENC price, last 12 months
Key stats
- Previous close
- $10.62
- Open
- $10.53
- Day range
- $10.51 – $10.81
- 52-week range
- $5.65 – $13.25
- Volume
- 105.1K
- Avg volume (20 days)
- 227.3K
- Market cap
- $371.9M
Performance
1W−0.1%
1M−12.9%
3M−3.8%
6M+62.9%
YTD+37.7%
1Y+26.3%
vs S&P 500, 1Y+9.5 pts
Technicals and fundamentals
About Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $371.9M